Provider records
Read the product that is actually named.
CoreAge’s first commercial position is disclosed. These reviews examine Spot On, Obagi Clear Rx and Dermatica while keeping cosmetic neighbors, formula menus and unresolved details separate.
Provider review
CoreAge Rx Spot On face cream: the preparation behind the promise
Current ingredients, the unresolved price statement and the professional questions a dark-spot offer leaves open.
Comparison
Hydroquinone face-cream routes: compare records before comparing strengths
Spot On, Obagi Nu-Derm Clear Rx and Dermatica answer different preparation, access and cost questions.
Provider review
Obagi Nu-Derm Clear Rx: keep the prescription record separate from Clear Fx
What the current 4% hydroquinone cream page establishes—and what a retail price for another product cannot answer.
Provider review
Dermatica hydroquinone face cream: read the proposed formula, not just the ingredient menu
A review of the current melasma pathway, advertised ingredients and the responsibilities left to an individual assessment.